Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10492948 | 0.86 | NR5A1 (0.53) | CNR2CNR1 | |
| SCHEMBL10513794 | 0.85 | NR5A1 (0.56) | CNR2CNR1 | |
| SCHEMBL988237 | 0.83 | CNR2 (0.51) | CNR2CNR1 | |
| SCHEMBL990538 | 0.82 | CNR2 (0.54) | CNR2CNR1 | |
| SCHEMBL7166616 | 0.81 | CNR2 (0.53) | CNR2CNR1 | |
| SCHEMBL4074135 | 0.81 | CYP3A4 (0.62) | CNR2CNR1 | |
| SCHEMBL4238919 | 0.81 | CNR2 (0.47) | CNR2CNR1 | |
| SCHEMBL2108030 | 0.81 | CYP3A4 (0.54) | CNR2CNR1 | |
| SCHEMBL1890228 | 0.80 | CNR2 (0.47) | CNR2CNR1 | |
| SCHEMBL1592413 | 0.80 | CYP3A4 (0.53) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117883308-A | Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one alkyl or alkylene carbonate | 莱雅公司 | 2024-04-16 | — | — | CN | disclosed |
| EP-4262719-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE CITRIC ACID ESTER | L'OREAL (FR) | 2023-10-25 | — | — | EP | disclosed |
| EP-4262714-A1 | COSMETIC COMPOSITION COMPRISING A MEROCYANINE, A TRIAZINE UV-SCREENING AGENT, AND A POLYSACCHARIDE MODIFIED WITH HYDROPHOBIC CHAINS | L'OREAL (FR) | 2023-10-25 | — | — | EP | disclosed |
| US-11679069-B2 | Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one alkyl or alkylene carbonate | L'OREAL (FR) | 2023-06-20 | — | — | US | disclosed |
| WO-2022129059-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE CITRIC ACID ESTER | L'OREAL (FR) | 2022-06-23 | — | — | WO | disclosed |
| WO-2022129039-A1 | COSMETIC COMPOSITION COMPRISING A MEROCYANINE, A TRIAZINE UV-SCREENING AGENT, AND A POLYSACCHARIDE MODIFIED WITH HYDROPHOBIC CHAINS | L'OREAL (FR) | 2022-06-23 | — | — | WO | disclosed |
| US-20210251868-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE ALKYL OR ALKYLENE CARBONATE | L'OREAL (FR) | 2021-08-19 | — | — | US | disclosed |
| EP-3827807-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE N-SUBSTITUTED AMIDE | L'OREAL (FR) | 2021-06-02 | — | — | EP | disclosed |
| US-11000460-B2 | Cosmetic or dermatological composition comprising a merocyanine, an oily phase and a C1—C4 monoalkanol | L'OREAL (FR) | 2021-05-11 | — | — | US | disclosed |
| EP-3813779-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE ALKYL OR ALKYLENE CARBONATE | L'OREAL SA (FR) | 2021-05-05 | — | — | EP | disclosed |
| EP-1549283-A1 | MEROCYANINE DERIVATIVES FOR COSMETIC USE | Ciba SC Holding AG (CH) | 2005-07-06 | — | — | EP | disclosed |
| WO-2005058269-A1 | MEROCYANINE DERIVATIVES FOR COSMETIC USE | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-06-30 | — | — | WO | disclosed |
| WO-2004085412-A2 | SYMMETRICAL TRIAZINE DERIVATIVES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-10-07 | — | — | WO | disclosed |
| US-20040191191-A1 | Symmetrical triazine derivatives | CIBA SPECIALTY CHEMICALS CORP. | 2004-09-30 | — | — | US | disclosed |
| WO-2004052837-A2 | AMINO SUBSTITUTED HYDROXYPHENYL BENZOPHENONE DERIVATIVES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-06-24 | — | — | WO | disclosed |
| WO-2004006878-A1 | MEROCYANINE DERIVATIVES FOR COSMETIC USE | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-01-22 | — | — | WO | disclosed |
| US-4551420-A | ULTRAVIOLET RAY ABSORBING POLYMER LATEX | FUJI PHOTO FILM CO., LTD. (JP) | 1985-11-05 | — | — | US | disclosed |
| US-4464462-A | ULTRAVIOLET RAY-ABSORBING ACRYLIC POLYMER LATEX; ANTISTATIC AGENTS | FUJI PHOTO FILM CO., LTD. (JP) | 1984-08-07 | — | — | US | disclosed |
| US-4455368-A | Silver halide photographic light-sensitive material containing a UV absorbing polymer latex | FUJI PHOTO FILM CO., LTD. (JP) | 1984-06-19 | — | — | US | disclosed |
| US-4443534-A | VINYL CHLORIDE HOMO- OR COPOLYMER, OR ACRYLAMIDE OR ACRYLIC ESTER HOMO- OR COPOLYMER | FUJI PHOTO FILM CO., LTD. (JP) | 1984-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11679069-B2 | Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one alkyl or alkylene carbonate | KRT18, DSG1, CUTA | CNR2 2430/4885CNR1 2447/4885 |
| US-20210251868-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE ALKYL OR ALKYLENE CARBONATE | KRT18, DSC1, DSG1 | CNR2 2138/4885CNR1 3012/4885 |
| US-20040191191-A1 | Symmetrical triazine derivatives | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, RNF168, CYC1 | CNR2 2544/4885CNR1 1273/4885 |
| US-11000460-B2 | Cosmetic or dermatological composition comprising a merocyanine, an oily phase and a C1—C4 monoalkanol | KRT18, C1S, C1R | CNR2 2028/4885CNR1 1686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.